InMode Acquires All The Intellectual Property Assets Of Viveve Medical; Terms Not Disclosed
All of Viveve's worldwide patents will be transferred and registered under InMode Ltd.Viveve is a medical technology company focused on women's wellness and the treatment of female stress urinary incontinence (SUI).
Viveve Medical (NASDAQ:VIVE) & Precision Optics (NASDAQ:POCI) Financial Comparison
Precision Optics (NASDAQ:POCI – Get Rating) and Viveve Medical (NASDAQ:VIVE – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses b
Viveve Medical (NASDAQ:VIVE) Cut to Neutral at Alliance Global Partners
Alliance Global Partners cut shares of Viveve Medical (NASDAQ:VIVE – Get Rating) from a buy rating to a neutral rating in a report published on Monday, The Fly reports. Viveve Medical Price Performan
Viveve Medical (NASDAQ:VIVE) Downgraded to "Neutral" at Alliance Global Partners
Alliance Global Partners lowered shares of Viveve Medical (NASDAQ:VIVE – Get Rating) from a buy rating to a neutral rating in a report issued on Monday morning, The Fly reports. Viveve Medical Price
Delisting of Securities of Schmitt Industries, Inc.; Viveve Medical, Inc.; and American Virtual Cloud Technologies, Inc. From The Nasdaq Stock Market
NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Schmitt Industries, Inc. Schmitt Industries, Inc.'s common stock was suspended on January 17,
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersOntrak (NASDAQ:OTRK) stock increased by 44.3% to $0.83 during Wednesday's pre-market session. The market value of their outstanding shares is at $22.4 million. TC BioPharm (Holdings) (NASDAQ:TC
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Celyad Oncology SA (NASDAQ:CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-21
Stocks That Hit 52-Week Lows On Tuesday
 Tuesday saw 9 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Embecta (NASDAQ:EMBC) is the largest company in terms of market cap to set a new 52-week low this mo
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
Viveve Medical Inc (NASDAQ:VIVE) announced topline results from the U.S. Pivotal PURSUIT clinical trial evaluating Viveve treatment for stress urinary incontinence (SUI) in women.The study did not mee
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCalyxt (NASDAQ:CLXT) stock increased by 140.3% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $21.7 million. Celyad Oncology (NASDAQ:CYAD) shares increased by
Viveve Crashes ~60% as Company Decides to Delist, Explore Sale After Trial Fails
Viveve Announces Topline Results From Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
Study's primary efficacy endpoint was not achieved at 12 months post-treatmentCompany has implemented a reduction in forceCompany will seek strategic alternatives and will be delisted from Nasdaq ENGL
Viveve Medical To Seek Strategic Alternatives And Will Be Delisted From Nasdaq; Company Announced Treatment For Female Stress Urinary Incontinence Did Not Meet Primary Endpoint
Viveve Medical, Inc. (NASDAQ:VIVE) today announced topline result from the U.S. Pivotal PURSUIT clinical trial. PURSUIT was a multicenter, randomized, double-blinded, sham-controlled U.S. study to eva
Tivic Health Systems (NASDAQ:TIVC) Versus Viveve Medical (NASDAQ:VIVE) Critical Review
Tivic Health Systems (NASDAQ:TIVC – Get Rating) and Viveve Medical (NASDAQ:VIVE – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesse
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersExact Sciences (NASDAQ:EXAS) shares increased by 17.9% to $52.6 during Friday's pre-market session. The company's market cap stands at $9.3 billion. IMAC Holdings (NASDAQ:BACK) shares increased
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence With Final 12-month Follow-up Visits Concluded
Topline results of the 12-month primary efficacy endpoint anticipated in January 2023Positive results may support a de novo marketing application for a new U.S. indication for treatment of stress urin
Short Interest in Viveve Medical, Inc. (NASDAQ:VIVE) Expands By 98.8%
Viveve Medical, Inc. (NASDAQ:VIVE – Get Rating) saw a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 178,100 shares, an incr
Stocks That Hit 52-Week Lows On Monday
 Monday saw 196 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Brookfield Asset Mgmt (NYSE:BAM
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Patent further strengthens Viveve's novel dual-energy technology intellectual property portfolio as company plans for completion of pivotal PURSUIT clinical trialENGLEWOOD, CO / ACCESSWIRE / December
Viveve Medical (NASDAQ:VIVE) Stock Price Passes Below 50 Day Moving Average of $0.64
Viveve Medical, Inc. (NASDAQ:VIVE – Get Rating) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.64 and traded as low as $0.45. Viveve
No Data